Abstract

Abstract We present a case of a female adolescent with severe acute Chagas myocarditis, acquired by oral transmission in an endemic area in the Brazilian western Amazon, who had electrocardiographic changes normalized after empirical treatment with the antiparasitic drug benznidazole combined with conventional treatment for severe heart failure.

Highlights

  • Chagas disease (CD) is a neglected parasitic infection caused by the protozoan Trypanosoma cruzi, which infects a wide range of triatomines and mammalian species, including man

  • Conventional treatment was started for severe heart failure with intravenous and oral administration of furosemide, carvedilol at increasing doses, spironolactone, and angiotensinconverting enzyme (ACE) inhibitors

  • Possible modes of transmission of CD include: feces of the infected vector deposited on the skin and/ or mucous membranes, while the vector sucks blood; transplacental vertical transmission which depends on maternal immune status, parasite strain and placental factors; lab accidents caused by violation of biosafety regulations; organ transplantation from an infected donor, oral transmission by ingestion of contaminated food, including açaí and sugarcane juice

Read more

Summary

Introduction

Chagas disease (CD) is a neglected parasitic infection caused by the protozoan Trypanosoma cruzi, which infects a wide range of triatomines and mammalian species, including man. Of CD treated with BZ and NFX had parasite persistence and progressive electrocardiographic changes, similar to untreated control patients.[4,5] The cardiac form of the disease starts with an acute dilated myocarditis, followed by myocardial remodeling, fibrosis, and arrhythmias. Conventional treatment was started for severe heart failure with intravenous and oral administration of furosemide, carvedilol at increasing doses, spironolactone, and angiotensinconverting enzyme (ACE) inhibitors. A concomitant transthoracic echocardiogram revealed normal cardiac chambers and normal left ventricular ejection fraction (63%). This significant response to BZ indicates that this drug can be effective in the treatment of the acute phase of Chagas myocarditis, but not the chronic phase.[4,5]

Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call